0.67
+0.01(+1.52%)
Currency In USD
| Previous Close | 0.66 |
| Open | 0.68 |
| Day High | 0.68 |
| Day Low | 0.65 |
| 52-Week High | 1.4 |
| 52-Week Low | 0.25 |
| Volume | 1.05M |
| Average Volume | 6.27M |
| Market Cap | 438.32M |
| PE | -5.58 |
| EPS | -0.12 |
| Moving Average 50 Days | 0.68 |
| Moving Average 200 Days | 0.54 |
| Change | 0.01 |
If you invested $1000 in Senseonics Holdings, Inc. (SENS) since IPO date, it would be worth $206.15 as of May 07, 2025 at a share price of $0.67. Whereas If you bought $1000 worth of Senseonics Holdings, Inc. (SENS) shares 5 years ago, it would be worth $1,250.47 as of May 07, 2025 at a share price of $0.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time
GlobeNewswire Inc.
Apr 29, 2025 8:05 PM GMT
GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
GlobeNewswire Inc.
Apr 29, 2025 11:30 AM GMT
twiist™ expands compatibility offerings to become the first AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 MANCHESTER, N.H. and GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIR
Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care
GlobeNewswire Inc.
Feb 26, 2025 12:30 PM GMT
Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care GERMANTOWN, Md.